The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Growth In Market Size Of The Chromatin immunoprecipitation (ChIP) Sequencing Market During 2026–2030?
The chromatin immunoprecipitation (chip) sequencing market size has seen rapid development recently. It is projected to expand from $15.48 billion in 2025 to $17.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. This growth observed historically is primarily due to the broadening of basic genomics research, increased financial support for academic research, the widespread availability of next-generation sequencing platforms, a surging interest in chromatin biology, and the proliferation of molecular biology laboratories.
The chromatin immunoprecipitation (chip) sequencing market is projected for significant expansion in the coming years, with its size anticipated to reach $29.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.6%. This expansion during the forecast period is fueled by factors such as increased funding in epigenomics research, the growing embrace of AI-powered genomic analysis, the spread of precision medicine programs, rising demand for integrated multi-omics approaches, and the expanding utilization of cloud-based bioinformatics solutions. Furthermore, key trends predicted for this period encompass a greater emphasis on genome-wide protein-DNA interaction mapping, the increasing prevalence of high-throughput sequencing technologies, a surge in the need for epigenetics research instruments, the development of integrated bioinformatics analysis workflows, and a heightened focus on regulatory genomics investigations.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13265&type=smp
What Are The Main Drivers Accelerating The Growth Of The Chromatin immunoprecipitation (ChIP) Sequencing Market?
The increasing prevalence of prostate cancer is expected to propel the growth of the chromatin immunoprecipitation (ChIP) sequencing market going forward. Prostate cancer is a type of cancer that develops in the prostate gland, a walnut-sized gland in men that produces fluid that helps semen. In prostate cancer research, ChIP-seq offers a comprehensive view of the molecular events driving the disease, providing critical information that can lead to a better understanding of its biology and the development of more targeted and effective therapeutic interventions. For instance, in January 2023, according to the American Cancer Society, a US-based cancer-fighting organization, in the US it is estimated that there were 288,300 new cases of prostate cancer and 34,700 deaths from prostate cancer in 2023. Therefore, the increasing prevalence of prostate cancer is driving the growth of the chromatin immunoprecipitation (ChIP) sequencing market.
How Is The Chromatin immunoprecipitation (ChIP) Sequencing Market Structured Across Different Market Segments?
The chromatin immunoprecipitation (chip) sequencing market covered in this report is segmented –
1) By Type: DNase-Sequencing, FAIRE-Sequencing
2) By Technology: Targeted Sequencing And Re-Sequencing, Whole Genome Sequencing And Whole Exome Sequencing
3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis
4) By Application: Consumables And Reagents, Service, Other Applications
5) By End-User: Academic Research Institutes, Clinical Research Institutes, Hospitals And Clinics, Pharmaceuticals And Biotechnology Companies, Other End Users
Subsegments:
1) By DNase-Sequencing: DNase I Hypersensitivity Mapping, DNase-Seq For Open Chromatin Regions
2) By FAIRE-Sequencing: Formaldehyde-Assisted Isolation Of Regulatory Elements (FAIRE), FAIRE-Seq For Active Regulatory Regions
Which Trends Are Affecting The Chromatin immunoprecipitation (ChIP) Sequencing Market Framework?
Major companies in the chromatin immunoprecipitation (ChIP) sequencing market are prioritizing novel technologies, such as hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing), to improve the precision and effectiveness of epigenomic investigations, thereby fostering progress in drug development and tailored medical treatments. hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing) itself represents a sophisticated method crafted to refine the examination of epigenetic changes throughout the genome. As an illustration, in June 2024, Epigenica, a life sciences technology firm located in Sweden, introduced its EpiFinder Platform. This platform incorporates patented hmqChIP-seq technology, facilitating high-throughput, multiplex quantitative analysis within epigenomic research. The groundbreaking platform allows researchers to produce 192 genome-wide profiles concurrently from as many as 24 samples, thereby simplifying extensive experiments with unparalleled velocity and economic advantage.
Which Industry Players Are Present In The Chromatin immunoprecipitation (ChIP) Sequencing Market?
Major companies operating in the chromatin immunoprecipitation (chip) sequencing market are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc. , PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Porvair Sciences Ltd. , Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.
Access The Complete Chromatin immunoprecipitation (ChIP) Sequencing Market Report:
Which Region Is The Dominant Market In The Chromatin immunoprecipitation (ChIP) Sequencing Market?
North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Chromatin immunoprecipitation (ChIP) Sequencing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=13265&type=smp
Browse Through More Reports Similar to the Global Chromatin immunoprecipitation (ChIP) Sequencing Market 2026, By The Business Research Company
Intravascular Ultrasound Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravascular-ultrasound-global-market-report
Vascular Imaging Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/vascular-imaging-global-market-report
Ocular Hypertension Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ocular-hypertension-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model